1. Home
  2. SEVN vs NNNN Comparison

SEVN vs NNNN Comparison

Compare SEVN & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seven Hills Realty Trust

SEVN

Seven Hills Realty Trust

N/A

Current Price

$6.70

Market Cap

167.9M

Sector

Real Estate

ML Signal

N/A

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

N/A

Current Price

$3.81

Market Cap

154.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SEVN
NNNN
Founded
1986
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
167.9M
154.1M
IPO Year
2008
2023

Fundamental Metrics

Financial Performance
Metric
SEVN
NNNN
Price
$6.70
$3.81
Analyst Decision
Buy
Analyst Count
5
0
Target Price
★ $8.70
N/A
AVG Volume (30 Days)
★ 175.7K
47.8K
Earning Date
10-27-2026
11-24-2026
Dividend Yield
★ 16.72%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.51
N/A
Revenue
★ $29,383,000.00
N/A
Revenue This Year
$15.13
N/A
Revenue Next Year
$16.21
N/A
P/E Ratio
★ $13.12
$446.57
Revenue Growth
N/A
★ N/A
52 Week Low
$5.98
$3.09
52 Week High
$9.81
$44.73

Technical Indicators

Market Signals
Indicator
SEVN
NNNN
Relative Strength Index (RSI) 49.08 45.71
Support Level $5.98 $3.21
Resistance Level $7.05 $6.95
Average True Range (ATR) 0.19 0.38
MACD 0.06 0.16
Stochastic Oscillator 64.21 59.36

Price Performance

Historical Comparison
SEVN
NNNN

About SEVN Seven Hills Realty Trust

Seven Hills Realty Trust is a real estate investment trust. The company is engaged in originating and investing in floating-rate first mortgage loans secured by middle-market and transitional commercial real estate. Its primary objective is to balance capital preservation with the generation of risk-adjusted returns. The company operates in one business segment: originating and investing in floating-rate first mortgage loans secured by CRE properties.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: